跳至主要内容
临床试验/NCT00036088
NCT00036088已完成4 期

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Eli Lilly and Company60 个研究点 分布在 10 个国家目标入组 530 人开始时间: 2001年8月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
530
试验地点
60

研究概览

简要总结

The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • You must be between the ages of 18 and
  • If you have reached your 76th birthday, you will not be able to participate
  • You must have been diagnosed with schizophrenia
  • You must be able to visit the doctor's office as scheduled for the next 7 months

排除标准

  • You have a serious medical illness, such as heart, liver, or kidney disease (Note: If you are uncertain about a particular condition, discuss it with your doctor.)
  • You are either pregnant or breastfeeding

研究者

申办方类型
Industry

研究点 (60)

Loading locations...

相似试验